Control Bleeding When Compression Isn’t Possible
WoundClot™ is a haemostatic dressing designed for rapid bleeding control in deep wounds, confined surgical fields and trauma situations where sustained compression is difficult or impractical.
When applied to a bleeding site, WoundClot™ quickly transforms from a dry, flexible gauze into a dense, durable, and expanding 3D gel matrix. This stable and adaptable structure supports fast, reliable hemostasis through multiple mechanisms of action.
Supports rapid haemostasis
While helping surgical teams maintain a clear operative field.
Reduces the need for prolonged manual compression
Allowing OR staff to focus on other critical tasks during procedures.
Cleared or approved in major regulatory markets
Including the U.S. FDA, CE Mark (Europe) and TGA (Australia).
Advanced Haemostatic Dressing for Surgery and Trauma
Why WoundClot™ is Different
Simple to place within the wound and designed to remain where applied.
No compression required
Most haemostatic dressings require sustained pressure. WoundClot™ promotes haemostasis without continuous compression.
Effective in deep or irregular wounds
Designed for wound cavities and confined surgical fields where compression may be difficult.
Rapid haemostasis
Rapid clot formation helps control bleeding and maintain a clear surgical field.
Designed for Critical Bleeding Control
Operating room bleeding control
Supports bleeding control in operating rooms where rapid haemostasis helps surgeons and theatre teams maintain a clear operative field.
Trauma and emergency care
Management of severe bleeding in emergency departments and trauma settings.
Military and tactical medicine
Rapid haemostasis in austere or field environments.
Resource Optimization
Traditional haemostatic gauze
Requires sustained manual pressure, often tying up clinical staff.
WoundClot™
The gel-state matrix maintains its position within the wound, helping control bleeding without continuous compression.
Regulatory Approvals
- U.S. FDA clearance
- CE Mark (Europe)
- TGA approval (Australia).
Published Clinical Evidence
Research and clinical reports for WoundClot™ emphasize its performance as a bio-absorbable, non-compressional hemostatic gauze across multiple surgical specialties including cardiovascular, spinal and orthopaedic procedures.
Clinical case studies and in-vitro evaluations demonstrate that the gauze rapidly forms a stable gel upon contact with blood, enhancing the natural coagulation process without requiring manual pressure.
Comparative analyses highlights its ability to manage high-pressure bleeding in delicate anatomical areas where traditional compression is restricted. Supporting documentation confirms its safety through extensive biocompatibility testing and successful application in complex procedures like lumbar decompression and tumour resections.
- Demonstrated rapid haemostasis in surgical settings
- Reduction in bleeding time reported in clinical studies
- Effective bleeding control in challenging wound environments
- Reduced bleeding time in clinical studies
- Effective management of bleeding in challenging wounds
FAQ: WoundClot™ Haemostatic Gauze
How is WoundClot™ different from other haemostatic gauzes?
Most haemostatic dressings rely on sustained manual compression to be effective. WoundClot™ is designed to promote haemostasis without continuous pressure. Its expanding 3D gel matrix conforms to and adheres to the wound site upon contact with blood. This makes it suitable for situations where maintaining compression is impractical, including deep wound cavities, confined surgical fields and pre-hospital environments.
It is also bio-absorbable, value-priced relative to comparable products and indicated for mild, moderate and severe bleeding.
WoundClot™ is specifically designed so that sustained manual compression is not required for haemostasis. When applied to a bleeding site, the gauze rapidly absorbs blood and transforms into a stable, expanding gel matrix that adheres to surrounding tissue and supports clot formation through multiple mechanisms. Light initial contact to place the dressing is all that is needed. This is a meaningful clinical distinction from most haemostatic gauzes, which require firm and prolonged manual pressure to activate. is specifically designed so that sustained manual compression is not required for haemostasis.
WoundClot™ is composed of a Non-Oxidised, Non-Regenerated Cellulosic Structure (NONRCS), which differs from oxidised regenerated cellulose products such as Surgicel. Key differences include:
- WoundClot™ does not require sustained compression;
- it absorbs significantly more blood relative to its weight;
- it has a faster resorption profile;
- it is indicated across mild, moderate and severe bleeding, whereas ORC products are generally indicated for mild to moderate bleeding only.
Independent in-vitro comparative data is available in the clinical resources section
FAQ: Practical Clinical Questions - OR / Theatre Settings
WoundClot™ is applied directly to the bleeding site with light contact to bring the gauze into position. No sustained compression is required. The gauze rapidly begins absorbing blood and forming a gel matrix that conforms to the wound cavity. It can be cut to size as needed and is suitable for use in confined anatomical spaces where traditional compression techniques are difficult to maintain. Full application guidance is provided in the product datasheet.
WoundClot™ is bio-absorbable and designed to be left in situ where clinically appropriate. It is fully resorbed by the body over time, which is a practical advantage in surgical settings where retrieval from a deep or confined wound cavity may be difficult. Where removal is preferred or required, its gel matrix supports atraumatic removal, reducing the risk of disrupting the formed clot – an issue associated with some kaolin- and silica-based products.
Yes. WoundClot™ is specifically designed for use in deep and irregular wound cavities where other haemostatic agents may be difficult to apply or maintain. Its gel matrix expands to conform to the wound shape and adheres to surrounding tissue without requiring external pressure. Biocompatibility has been confirmed through extensive testing. Clinical evidence includes use in spinal, cardiovascular, orthopaedic and gynaecological procedures – settings where access is often restricted and compression is not feasible.
FAQ: EMS, Trauma and Military
Yes. WoundClot™ Trauma is designed for use in emergency and pre-hospital environments, including field medicine and tactical care settings. Its non-compression mechanism is particularly relevant in these contexts – maintaining sustained pressure on a wound is often impractical during patient transport, in confined spaces or under operational conditions. The gauze is simple to apply, requires no specialist training beyond standard haemostatic dressing protocols and is compact for inclusion in trauma kits.
WoundClot™ is designed for rapid haemostasis. Upon contact with blood, the gauze begins absorbing fluid and forming a gel matrix within seconds. Clinical studies have demonstrated significant reductions in bleeding time compared to standard gauze. Specific performance data from published clinical evaluations is available in the resources section
Yes. WoundClot™ WoundClot may be used in penetrating trauma including gunshot wounds. Its ability to conform to irregular wound cavities without requiring compression makes it suitable for gunshot wounds and other penetrating injuries where wound geometry makes sustained manual pressure difficult or impossible. It has been evaluated in trauma and military medical contexts. For detailed clinical guidance on specific wound types, refer to the published clinical evidence in the resources section.
FAQ: Procurement and Regulatory
WoundClot™ holds regulatory approval in several major medical markets including
- U.S. FDA clearance
- CE Mark (Europe)
- TGA approval (Australia).
These approvals confirm that the product meets the safety, performance and quality standards required in each respective market. Documentation is available on request.
Evaluation samples are available to healthcare professionals and medical institutions. To request a sample, please ask your local distributor or complete the clinical enquiry form. Requests are reviewed by our clinical support team and directed to the appropriate regional contact. Sample availability may vary by country depending on local distribution arrangements.
WoundClot™ is distributed internationally through authorised medical distribution partners. If you are in a country where distribution is already established, your enquiry will be directed to your local partner. If WoundClot™ is not yet available in your region, our team will advise on the current status. Please submit your question or register your interest here.
Clinical Evaluation and Distribution
Evaluation samples available to healthcare professionals and medical institutions.
Distribution Enquiries
WoundClot™ is supplied internationally through authorised medical distribution partners.
Enquiries from established medical device distributors are welcome.